Literature DB >> 15890764

Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus.

R J van der Schaaf, J P S Henriques, J J Wiersma, K T Koch, J Baan, K J J Mulder, J D Durrer, J G P Tijssen, J J Piek, R J de Winter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15890764      PMCID： PMC1861002          DOI： 10.1136/hrt.2004.059675

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  K H Mak; D J Moliterno; C B Granger; D P Miller; H D White; R G Wilcox; R M Califf; E J Topol
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

2.  Long-term, cause-specific mortality after myocardial infarction in diabetes.

Authors:  Jorik R Timmer; Jan Paul Ottervanger; Karen Thomas; Jan C A Hoorntje; Menko-Jan de Boer; Harry Suryapranata; Felix Zijlstra
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

Review 3.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

4.  Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis.

Authors:  L F Hsu; K H Mak; K W Lau; L L Sim; C Chan; T H Koh; S C Chuah; R Kam; Z P Ding; W S Teo; Y L Lim
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

5.  Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction.

Authors:  Michael N Zairis; Anastassios G Lyras; Stamatis S Makrygiannis; Paraskevi K Psarogianni; Evdokia N Adamopoulou; Stelios M Handanis; Apostolos Papantonakos; Spyros K Argyrakis; Athanasios A Prekates; Stefanos G Foussas
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112
  5 in total
  4 in total

1.  Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction.

Authors:  Mayra Tisminetzky; Samuel Joffe; David D McManus; Chad Darling; Joel M Gore; Jorge Yarzebski; Darleen Lessard; Robert J Goldberg
Journal:  Diab Vasc Dis Res       Date:  2014-03-11       Impact factor: 3.291

2.  Radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery. Mid-term results.

Authors:  G Lazopoulos; C Mihas; M Manns-Kantartzis; M Kantartzis
Journal:  Herz       Date:  2013-03-30       Impact factor: 1.443

3.  Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris.

Authors:  Jacobijne J Wiersma; Hein J Verberne; Wik L ten Holt; Ineke M Radder; Lea M Dijksman; Berthe L F van Eck-Smit; Mieke D Trip; Jan G P Tijssen; Jan J Piek
Journal:  J Nucl Cardiol       Date:  2009-06-18       Impact factor: 5.952

4.  Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: role of type 2 diabetes mellitus.

Authors:  Zhang Han; Yang Yan-min; Zhu Jun; Liu Li-sheng; Tan Hui-qiong; Liu Yao
Journal:  BMC Cardiovasc Disord       Date:  2012-11-15       Impact factor: 2.298
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.